Literature DB >> 21590391

Introduction to viral vectors.

James N Warnock1, Claire Daigre, Mohamed Al-Rubeai.   

Abstract

Viral vector is the most effective means of gene transfer to modify specific cell type or tissue and can be manipulated to express therapeutic genes. Several virus types are currently being investigated for use to deliver genes to cells to provide either transient or permanent transgene expression. These include adenoviruses (Ads), retroviruses (γ-retroviruses and lentiviruses), poxviruses, adeno-associated viruses, baculoviruses, and herpes simplex viruses. The choice of virus for routine clinical use will depend on the efficiency of transgene expression, ease of production, safety, toxicity, and stability. This chapter provides an introductory overview of the general characteristics of viral vectors commonly used in gene transfer and their advantages and disadvantages for gene therapy use.

Entities:  

Mesh:

Year:  2011        PMID: 21590391     DOI: 10.1007/978-1-61779-095-9_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  39 in total

1.  Influence of caspase-3 silencing on the proliferation and apoptosis of rat bone marrow mesenchymal stem cells under hypoxia.

Authors:  Ping Hua; Jialiang Liu; Jun Tao; Jianyang Liu; Songran Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.

Authors:  Patrick M Younan; Christopher W Peterson; Patricia Polacino; John P Kowalski; Willimark Obenza; Hannah W Miller; Brian P Milless; Phil Gafken; Stephen C DeRosa; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

Review 3.  Overcoming Challenges in Process Development of Cellular Therapies.

Authors:  Steven L Highfill; David F Stroncek
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

4.  Institutional Oversight of Occupational Health and Safety for Research Programs Involving Biohazards.

Authors:  Melissa C Dyson; Calvin B Carpenter; Lesley A Colby
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 5.  Gene targeting in ischemic heart disease and failure: translational and clinical studies.

Authors:  Shaina R Eckhouse; Jeffrey A Jones; Francis G Spinale
Journal:  Biochem Pharmacol       Date:  2012-08-28       Impact factor: 5.858

6.  Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.

Authors:  Elisa Vigna; Giovanni Pacchiana; Cristina Chiriaco; Simona Cignetto; Lara Fontani; Paolo Michieli; Paolo M Comoglio
Journal:  J Mol Med (Berl)       Date:  2013-09-07       Impact factor: 4.599

7.  Inhibition of striatal-enriched tyrosine phosphatase 61 in the dorsomedial striatum is sufficient to increased ethanol consumption.

Authors:  Emmanuel Darcq; Sami Ben Hamida; Su Wu; Khanky Phamluong; Viktor Kharazia; Jian Xu; Paul Lombroso; Dorit Ron
Journal:  J Neurochem       Date:  2014-03-27       Impact factor: 5.372

8.  Effective isotope labeling of proteins in a mammalian expression system.

Authors:  Mallika Sastry; Carole A Bewley; Peter D Kwong
Journal:  Methods Enzymol       Date:  2015-10-23       Impact factor: 1.600

Review 9.  Gene transfer to the outflow tract.

Authors:  Yalong Dang; Ralitsa Loewen; Hardik A Parikh; Pritha Roy; Nils A Loewen
Journal:  Exp Eye Res       Date:  2016-04-27       Impact factor: 3.467

10.  Efficient viral delivery system for unnatural amino acid mutagenesis in mammalian cells.

Authors:  Abhishek Chatterjee; Han Xiao; Michael Bollong; Hui-Wang Ai; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.